| __timestamp | Takeda Pharmaceutical Company Limited | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 520990000000 | 60987000 |
| Thursday, January 1, 2015 | 535405000000 | 125542000 |
| Friday, January 1, 2016 | 558755000000 | 210460000 |
| Sunday, January 1, 2017 | 495921000000 | 275119000 |
| Monday, January 1, 2018 | 659690000000 | 409539000 |
| Tuesday, January 1, 2019 | 1089764000000 | 547758000 |
| Wednesday, January 1, 2020 | 994308000000 | 736300000 |
| Friday, January 1, 2021 | 1106846000000 | 904200000 |
| Saturday, January 1, 2022 | 1244072000000 | 1080300000 |
| Sunday, January 1, 2023 | 1431505000000 | 1262200000 |
| Monday, January 1, 2024 | 1431505000000 | 1530500000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial. This chart compares the cost of revenue for Vertex Pharmaceuticals Incorporated and Takeda Pharmaceutical Company Limited from 2014 to 2023. Takeda, a Japanese multinational, consistently outpaces Vertex, an American biotech firm, in cost of revenue. In 2023, Takeda's cost of revenue was approximately 1.4 trillion, a staggering 1,100 times more than Vertex's 1.3 billion. This disparity highlights Takeda's expansive operations and market reach. Over the decade, Takeda's costs grew by 175%, while Vertex's increased by 1,970%, reflecting its rapid growth trajectory. However, data for Vertex in 2024 is missing, indicating potential reporting delays or strategic shifts. This comparison underscores the diverse strategies and scales of these pharmaceutical powerhouses, offering insights into their operational efficiencies and market strategies.
Gross Profit Comparison: Vertex Pharmaceuticals Incorporated and Takeda Pharmaceutical Company Limited Trends
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Dr. Reddy's Laboratories Limited
Cost Insights: Breaking Down Vertex Pharmaceuticals Incorporated and Alkermes plc's Expenses
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Supernus Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated vs Wave Life Sciences Ltd.: Efficiency in Cost of Revenue Explored
Takeda Pharmaceutical Company Limited vs Neurocrine Biosciences, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs United Therapeutics Corporation
Takeda Pharmaceutical Company Limited vs Insmed Incorporated: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs Dr. Reddy's Laboratories Limited
Cost of Revenue: Key Insights for Takeda Pharmaceutical Company Limited and Corcept Therapeutics Incorporated
Analyzing Cost of Revenue: Takeda Pharmaceutical Company Limited and Amphastar Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for Takeda Pharmaceutical Company Limited and Evotec SE